. Intracellular expression profiling by laser capture microdissection: three novel components of the neuromuscular junction.
A MATURE MYOFIBER typically contains Ͼ100 myonuclei, with three regional "myonuclear domains" identified: neuromuscular junction (NMJ), myotendinous junction (MTJ), and extrajunctional regions (XNMJ) (12) . The mRNA expression patterns of these three myonuclear domains are thought to be relatively distinct, although they change as a function of development and can show interdomain communication (1, 3, 31) .
The NMJ has been considered a classical model for the establishment and maintenance of nuclear domains and the extent to which gene expression is restricted at these regions. A classical example of such restricted gene transcription is the almost exclusive expression of acetylcholine (ACh) receptor (AChR) subunits at the NMJ (13) . Although NMJs consist of Ͻ0.1% of the muscle fiber surface, they contain Ͼ95% of the AChRs (43) .
There are three developmental phases involved in the formation of the NMJ. During myofiber development or regeneration, before innervation, certain NMJ components are expressed throughout the muscle fiber (e.g., nicotinic AChRs). Once a motor neuron contacts the myofiber, expression of these components is suppressed at noncontact regions, leading to highly localized, restricted myonuclear domains for these components. Synapse-specific transcription program by the subsynaptic nuclei is initiated along with the transcriptional arrest of NMJ-specific genes (such as AChRs) in non-NMJ myonuclei (32) (33) (34) .
A key event in the localization and stabilization of the NMJ is the release of agrin by the motor neuron terminal. Agrin, a proteoglycan released by the motorneuron, induces AChR clustering (25) . Agrin-deficient knockout (KO) mice lack differentiated NMJs and die soon after birth due to respiratory failure (14) . Muscle-specific kinase (MuSK), a receptor tyrosine kinase that undergoes autophosphorylation (48) , is the main component of the agrin-binding complex (20) . Signaltransducting molecules are then thought to bind to these sites and propagate the necessary signaling cascade, although these downstream pathways are poorly defined. As with many receptor tyrosine kinases, MuSK does not bind agrin directly but through a poorly defined "myotube-associated specificity complex" (MASC) (15) . Other neurotrophic factors known as ARIA [AChR-inducing activity, or neuregulin (NRG)] also activate transcription of AChR genes at the NMJ myonuclei (34, 35) . Rapsyn is also an NMJ-specific protein that interacts with AChRs and directly binds to the cytoplasmic domain of ␤-dystroglycan (4, 8) . Further studies have indicated that rapsyn is not required for MuSK phosphorylation (2) . Therefore, the nature of protein kinases and phosphatases responsible for MuSK activation and regulation remains unknown. Apel et al. (2) suggested that a putative rapsyn-associated transmembrane linker protein (RATL) may facilitate rapsynMuSK linkage.
Upon formation and stabilization of the NMJ, the concentration of AChRs at the postsynaptic membrane reaches up to 10,000 molecules/m 2 , whereas it is reduced to as low as 10/m 2 molecules at the XNMJ (33) . Thus the formation and stabilization of the NMJ myonuclear domain is critical for appropriate contact and signaling between the motor neuron and myofiber. Considerable progress has been achieved in defining many of the protein-protein signaling events during this process (22) , but less is known regarding the protein components of the NMJ and the transcriptional events at this region.
The specific and comprehensive transcription program of NMJ-associated nuclei (of motorneuron, myofiber, and Schwann cells) has not been previously established because of many obstacles in dealing with NMJs. The main obstacles in doing so have been the relatively small size of the NMJ (35-90 m) and the low abundance of these in muscle tissue (1 per myofiber, where the myofiber itself stretches from tendon to tendon). We hypothesized that we could define the specific transcription program of the NMJ by combining emerging technologies, namely laser capture microdissection (LCM) coupled with RNA amplification Affymetrix GeneChip arrays. Here we report technique development [isolation of NMJs by LCM, and mRNA profiling of small RNA amounts (Ͼ0.5 ng)] and definition of candidates of mRNAs corresponding to the NMJ-associated nuclei. We also present protein validation of three of these potential NMJ-localized transcripts.
MATERIALS AND METHODS

Mice
Eight (2-mo-old C57Bl/10) mice were euthanized by cervical dislocation, and tibialis anterior (TA) muscles were collected. The tissue was immediately frozen in isopentane cooled in liquid nitrogen and stored at Ϫ80°C. Muscle samples were used for laser microdissection (2 mice), immunostaining, and cDNA synthesis (6 mice). All animal procedures and experiments complied fully with the principles set forth in the "Guide for the Care and Use of Laboratory Animals" prepared by the Committee on Care and Use of Laboratory Animals of the Institute of Laboratory Resources, National Research Council, and were approved by the Children's National Medical Center's Institutional Animal Use and Care Committee.
Tissue Dehydration and NMJ Collection by LCM
Mouse TA muscle was sectioned (8-m thick) on RNase Away (Ambion, Austin, TX)-treated Superfrost Plus (Fisher Scientific, Houston, TX) microscope glass slides. NMJs were then stained for acetylcholinesterase (see below). Slides were then washed with 70% ethanol for 30 s and four rounds of 100% ethanol for 1 min each, placed in xylene for 5 min, and finally placed in hood to air dry for 30 min.
Dehydrated tissues were used immediately for NMJ and XNMJ microdissection. Arcturus HS CapSure caps (Arcturus, Mountain View, CA) were used to collect cells. LCM was operated as described by the manufacturer.
NMJ Identification by Acetylcholinesterase Staining
Karnowsky and Root's method was used for NMJ localization. Briefly, acetylcholinesterase was stained during an enzymatic process, using acetylthiocholine iodide. Five milligrams of acetylthiocholine iodide were dissolved in 0.1 M sodium acetate buffer (pH 5.2). To this solution, 0.5 ml of 0.2 M sodium citrate, 1 ml of 30 mM cupric sulfate, 1 ml of H 2O, and 1 ml of 5 mM potassium ferricyanide were added and mixed. Three hundred microliters of this solution were placed on sectioned tissues for 25 min until sufficient red/brown color developed.
RNA Amplification and Expression Profiling
Roughly 1,000 NMJs were microdissected per experiment. Stratagene (La Jolla, CA) Nanoprep RNA isolation kit was used to isolate RNA from the caps. Isolated total RNA was then subjected to two rounds of T7-based cRNA amplification to yield biotin-labeled cRNA.
Briefly, 50-100 ng of total RNA were converted to double-stranded cDNA, using a T7-promoter primer. This cDNA was then used as a template to derive the production of cRNA using the Megascript T7 in vitro transcription kit (Ambion, Austin, TX). For the second-round amplification, 200 ng of the first round-amplified cRNA were used to synthesize double-stranded cDNA, first using a random primer to drive the first-strand synthesis and then using the T7 promoter/primer to derive the second-strand synthesis. This amplified cDNA was used to synthesize biotinylated cRNA from the T7 promoter using the Enzo BioArray High Yield RNA transcription labeling kit (Enzo, New York, NY). Biotin-labeled cRNA was then cleaned up using RNeasy minicolumns. Twelve to sixteen micrograms of labeled cRNA were then fragmented and hybridized to MG-U74A v.2 Affymetrix GeneChip probe arrays. Hybridization and detection of hybridized probes were performed as described in the GeneChip Expression Analysis Technical Manual. Present call for the four U74A v.2 chips were 23, 29, 25.9, and 26.9%. The GAPDH 3Ј/5Ј ratios were 5.3, 1.4, 5.52, and 7.4, respectively. All profiles of this experiment are accessible via a public website (http://www.ncbi.nlm.nih.gov/geo/; accession nos. GSM-38542, GSM-38543, GSM-38545, GSM-38544).
Quantitative Multiplex Fluorescence-RT-PCR
Total RNA was isolated from both NMJ and XNMJ of three mice, using LCM as described before, and amplified one time to obtain cRNA. About 200 ng of cRNA were then used to produce singlestranded cDNA, and then 10 ng of cDNA were input into each reaction for quantitative RT-PCR.
The RT-PCR method involves the coamplification of both a control (bone morphogenesis protein-4; BMP4) and an experimental mRNA in the same reaction (53) . PCR reactions were done and the products resolved using automated sequencers. Infrared fluorescent-labeled (LiCor, Lincoln, NE) and nonfluorescent-labeled primers (Invitrogen, Carlsbad, CA) were designed and synthesized according to Supplemental Table S1 (available at the Physiological Genomics web site). 1 The RT-PCR mixtures included 1.0 l of cDNA, 10ϫ PCR buffer, dNTPs, each primer (1 pmol), and Taq Gold DNA polymerase (Perkin Elmer, Foster City, CA). Cycling conditions were 94°C for 12 min and 24-27 cycles of 94°C for 30 s, 55°C for 30 s, and 72°C for 1 min. Reactions were then mixed with denaturing solution and denatured at 95°C for 5 min. Denatured solutions were then run on 5% polyacrylamide gels, using LiCor automated sequencers. The LiCor sequencer scanner allowed detection of the intensity of the fluorescent signal for each product. The Scanalytics (Fairfax, VA) software provided a nanogram intensity value for each band corresponding to the quantitative measure of the relative levels of mRNA. The quantity of the expression level for each experimental gene vs. each control gene was calculated, based on the ratio between the intensity value of the experimental gene and the control sample (BMP4), for a total of three comparisons for the NMJ group and three for the XNMJ group (see Fig. 5 ). Student's t-test was performed to generate P values between NMJ and XNMJ for each experimental gene.
Immunohistochemistry
Polyclonal antibodies have been used successfully by others (7) for detecting NMJ-associated molecules such as nestin. To increase specificity and reduce unspecific staining, we chose to use affinitypurified polyclonal antibodies raised against synthetic peptides. Polyclonal rabbit anti-mouse antibodies were generated by Bethyl Laboratories (Montgomery, TX). The following peptides were used to produce antibodies: dual-specificity phosphatase-6 (DUSP6), CDIES-DLDRDPNSATDSDGSPLS and CDNRVPTPQLYFTTPSNQN-VYQVDSLQST; ribosomal receptor-binding protein-1 (RRBP1), CKTKKKEEKPNKIPEHD and CQEAPKQDAPAKKKSGSRKKG; vacuolar protein sorting-26 (VPS26), CGETRKMAEMKT-EDGKVEKHY and CKLRKQRTNFHQRFESPDSQASAEQ. Briefly, peptides were synthesized and conjugated to keyhole limpet hemocyanin (KLH) before being injected into rabbits. Hyperimmune serum from rabbits was processed over the respective immunosorbent assay to capture antibodies specific for each peptide. ␣-Bungarotoxin antibody was purchased from Calbiochem (San Diego, CA) and cy3-conjugated donkey anti-rabbit secondary antibody was purchased from Jackson Laboratory (Bar Harbor, ME).
Serial 5-m-thick frozen mouse TA muscle sections were cut with cryostat, mounted on Superfrost Plus slides (Fisher Scientific), and fixed in cold anhydrous acetone. Sections were then blocked for 15 min in 5% horse serum and 1ϫ PBS and incubated with primary antibody (1:10,000) for 1 h at room temperature. Washes (3 for 5 min each) were done with 5% horse serum and 1ϫ PBS, and sections were then incubated with secondary antibody for 1 h.
In Situ Hybridization
The design of oligonucleotide probes for DUSP6 was done with the Helios BioSciences (Paris, France) software OligoETC. Four distinct, nonoverlapping anti-sense probes and the corresponding sense control probes were synthesized based on the DUSP6 sequence; all were confirmed for uniqueness via comparison to the murine genome. Frozen sections of mouse TA muscle were first postfixed in paraformaldehyde, histochemically stained for acetylcholinesterase (50) , and then hybridized for in situ detection of DUSP6 mRNA. The four anti-sense oligonucleotides were end-labeled with 35 S-nucleotides, using terminal deoxynucleotide transferase (TdT), mixed, and cohybridized to frozen sections. Parallel sections were hybridized to the control sense mix of four labeled oligonucleotides. Hybridized and washed slides were then coated with emulsion, exposed for 2 wk, and developed. Slides were counterstained with hematoxylin and eosin.
RESULTS
NMJ Isolation and Expression Profiling
To isolate NMJs, we employed LCM (Arcturus). Briefly, longitudinal frozen sections of TA muscle were mounted on microscope slides and dehydrated. A histochemical stain was done for ACh-esterase (AChE), with the complete staining procedure reduced to 10 min to minimize mRNA degradation (Fig. 1A) . A "cap" containing a thin thermoplastic (ethylene vinyl acetate) film was then placed on the stained sections, a low-power laser beam was directed to 7.5-m areas stained positively with AChE, and three laser pulses were used to collect each NMJ (Fig. 1) . We found two technical hurdles to requiring optimization. One was appropriate dehydration (see MATERIAL AND METHODS). The second was nonspecific adherence of pieces of tissue to the cap. Arcturus (Mountain View, CA) provides adherence pads (CapSure cleanup pads) to aid in cleaning undesired material from the caps. However, we found these pads insufficient for NMJs. First, these highly adhesive pads removed NMJs along with the unwanted tissues. Second, the pads are opaque, making it impossible to observe the specific regions eliminated from the cap using the microscope. We overcame this obstacle by using transparent Post-it adhesive notes (3M, St. Paul, MN). The relatively low degree of adhesiveness of Post-it notes permitted the removal of loosely adhering nonspecific tissue. At the same time, the transparency of the material allowed the visualization of the cap surface so the operator can choose the area to be cleaned (Fig. 2, A-D) . We also found that mRNA integrity was best when the tissue processing through to RNA isolation was done in 4 h or less.
A quality control metric for Affymetrix arrays is the percentage of "present" calls (44) . This metric measures the percentage of probe sets on the microarray where the signal intensity difference between the 11 perfect-match and 11 paired-mismatch probes is above a specific threshold. This is a method of approximating background or nonspecific hybridization to probe sets, and values of 30-40% present calls are considered adequate signal-to-noise ratios when one round of amplification is used. In the case of two rounds of amplification, as presented here, the percentage of present calls is typically not as high as with one round. All of the microarrays presented here showed a percentage present call Ͼ23%. A second metric is an approximate measure of cDNA integrity, assessed by relative expression of probe sets at the 3Ј-and 5Ј-ends of the same transcript. Typical measures of GAPDH 3Ј/5Ј ratios for one round of amplification are Ͻ3.0. Again, these quality control metrics must be relaxed for LCM and two rounds of amplification. All of our samples showed GAPDH 3Ј/5Ј ratios of Ͻ7.4, with an average of 4.9 (see MATERIALS AND METHODS).
We hybridized four Affymetrix U74A v.2 GeneChips (2 NMJs and 2 non-NMJs) and queried 12,000 genes. Signal intensities for each probe set were generated using Microarray Suite (MAS)5. Signal intensity values were compared by pairwise analyses of the four microarray profiles, and only those probe sets showing at least one "present call" were retained for further analyses (4,633/12,424 probe sets; 37% of total probe sets). NMJ-enriched transcripts were defined as those that showed higher expression (Ͼ2-fold) in the NMJ profiles relative to non-NMJ. This analysis generated a list of 143 genes that were then correlated with fold-change approximations (Table 1) .
We first interrogated the 143 gene list for documented NMJ-associated transcripts and/or proteins. ⑀-AChR, ␣-AChR, and nestin were each known NMJ-enriched transcripts that were detected as significantly enriched in the NMJ expression profiles (Table 1, top) . We also used a less stringent approach, where MAS4 probe set signals were compared with the use of pairwise analyses of the four microarray profiles (Supplemental Table S2 ). This nonstatistical analysis showed more extensive gene lists showing strong fold changes between NMJs and non-NMJs and included additional known NMJ-associated transcripts (acetylcholinesterase, nestin, and ␣-dystrobrevin). Nestin is a member of intermediate filament (IF) protein family (24) . Initial studies had indicated that nestin expression is high during early developmental stages, whereas it decreases in adult myofiber (39) . However, Vaittinen et al. (45) showed that nestin localizes exclusively to MTJs and NMJs.
We prioritized differentially expressed transcripts by focusing on those that showed strong enrichment at the NMJ, as suggested by the strongest P values and highest fold changes. We further prioritized this subset by querying for muscle specificity in GenBank [e.g., expressed sequence tags (ESTs) originally identified in muscle, heart, or both] and by literature inquiries regarding known or possible function and possible relevance to nerve-muscle interaction. Three transcripts were chosen for further validation: DUSP6, RRBP1, and VPS26.
Quantitative Multiplex Fluorescence-RT-PCR and Immunostaining Assays
To validate our expression profile data, we performed quantitative multiplex fluorescence (QMF)-RT-PCR using infrared primers (11, 53) . Initially, we selected nestin, a known NMJassociated gene, as a positive control for QMF-RT-PCR analysis. Nestin is known to be highly enriched at the NMJ (45). To select a control gene that is equally expressed in NMJ and XNMJ, we analyzed our data with GeneSpring software (Silicon Genetics, Redwood City, CA). On the basis of signal intensities and present/absent calls, we identified transcripts that were of similar signal to our test transcripts, yet were predicted to be equally expressed at both NMJ and XNMJ from the microarray data. From this list, we selected BMP4 as the control gene. We used LCM to isolate roughly 400 NMJs and an equal area of the non-NMJs. RNA was isolated, and singlestrand cDNA was synthesized and used as templates for PCR. QMF-RT-PCR analysis confirmed the high expression of nestin at the NMJs (Fig. 3) , whereas BMP4 (the control gene) was shown to be expressed equally between NMJ and non-NMJ. We then performed QMF-RT-PCR on the selected transcripts and validated the high expression of DUSP6, RRBP1, and VPS26 (Fig. 3) .
To further validate the expression profiling data, we produced affinity-purified polyclonal antibodies to the three selected genes (DUSP6, VPS26, and RRBP1). For each transcript, two nonoverlapping peptides were designed against hydrophilic regions that showed little or no homology to other proteins in the National Center for Biotechnology Information GenBank. The peptides were conjugated to KLH and coimmunized into rabbits, with resulting sera affinity purified using each immobilized peptide separately. The affinity-purified peptide antibodies were then tested for specificity and sensitivity, using primarily immunostaining of mouse TA muscle, although DUSP6 antibodies were also tested by immunoblot using Torpedo electroplaques and mass spectrometer identification (data not shown). DUSP6 was also validated by in situ hybridization, as described below. DUSP6. DUSP6 is a 42-kDa cytoplasmic protein that dephosphorylates the "classical" growth factor-activated MAPKs ERK1 and ERK2 but not stress-activated MAPKs (17, 27) . Dual-specificity protein phosphatases (DSPs) have been shown to catalyze the removal of phosphate groups form threonine and tyrosine residues, within a signature sequence of TXY, that are essential for the enzymatic activity (6) .
With the use of expression profiling, DUSP6 was found to be highly expressed at the NMJ (7.2-fold) compared with the non-NMJ (Table 1) . QMF-RT-PCR confirmed the high expression levels of this protein at the NMJ (Fig. 3) . We also employed in situ hybridization assays and showed the localization of DUSP6 mRNA to the NMJ (Fig. 4 , Aa and Ab), confirming our QMF-RT-PCR results, whereas the sense strand probes (negative control) failed to produce detectable signals (Fig. 4B) . Immunostaining assays, using either of the two anti-peptide antibodies, showed that DUSP6 localized to the NMJ (Fig. 5Aa ) in serial sections of mouse TA muscle compared with ␣-bungarotoxin (␣-BTX) immunostaining (Fig.  5Ab) .
Our laboratory has previously identified transcriptional regulatory pathways specific to mouse muscle regeneration by generating temporal expression profiles (51, 52) . Query of DUSP6 in the 27-time point in vivo muscle regeneration series showed transient increases in expression, as one would expect for a component of the NMJ (Fig. 6) . Specifically, DUSP6 expression showed highest expression at 2-3 days during regeneration (5-fold increase relative to time 0 at 2 days postinjection). This preceded the upregulation of ␣-AChR (10-fold at 3 days) and nestin (4.5-fold at 3.5 days postinjection).
RRBP1. RRBP1 (also called ES/130, p180) was originally reported as a heart morphogenesis inducer in chicken embryonic heart (30). RRBP1 is a membrane protein with a short luminal tail, with most of the protein projected into the cytoplasmic region (23) . By expression profiling, we found high expression levels of RRBP1 at the NMJ compared with the non-NMJ (Table 1 ). This was confirmed by quantitative RT-PCR (Fig. 3) . Of the two affinity-purified peptide antisera produced against RRBP1, one showed colocalization with BTX to the NMJ (Fig. 5 , Ba and Bb), whereas the second showed high background staining in muscle and was not studied further. Query of RRBP1 in the 27-time point muscle regeneration series showed transient induction, with a peak expression at 2 days (Ͼ2-fold; Fig. 6 ). Similar to DUSP6, the RRBP1 transcriptional induction correlated roughly with that of nestin and ␣-AChR, although increased expression was sustained for a longer time period during regeneration.
VPS26. Organelles in eukaryotic cells are maintained by their specific organelle sorting proteins such as VPS26. VPS26, a 38-kDa protein, is the mammalian homolog of yeast vacuolar protein sorting-26 (Vps26p). Microarray showed VPS26 to be highly enriched at the NMJ (Table 1 ), a finding confirmed by QMF-RT-PCR (Fig. 3) . Immunostaining assays using both peptide antibodies showed that VPS26 localized to the NMJ in serial sections of mouse TA muscle compared with ␣-BTX immunostaining (Fig. 5 , Ca and Cb). Secondary antibodies, primary antibodies mixed with competing peptides, and preimmune sera were also used as negative controls (data not shown). The use of preimmune sera did not stain the NMJs.
DISCUSSION
Identification of Potential Components of the NMJ by LCM and Expression Profiling
The NMJ has been studied as a prototypical synapse for decades, and considerable knowledge exists concerning molecular structure (34) and molecular function (22) . Nevertheless, it is likely that many if not most components of the NMJ remain undiscovered. For example, two proteins/complexes have been hypothesized to exist, based on observed signaling cascades (MASC, RATL), yet the identity of these proteins or corresponding genes remains unknown (2, 15) . Studies of the NMJs are complicated by the small size of the region, difficulties in applying standard fractionation techniques for NMJ isolations, and the nature of nuclear domains within a syntium that defines the NMJ transcriptome. Here we report use of LCM methods to isolate NMJs and compare the mRNA profiles of NMJ-enriched fractions with non-NMJ captured material. 
Validation of DUSP6, RRBP1, and VPS26 as Novel Components of the NMJ
We focused on three potential novel components of the NMJ that were detected by LCM microarray analyses: DUSP6, RRBP1, and VPS26. To validate these three proteins as novel components of the NMJ, we first used quantitative RT-PCR from distinct LCM preparations (Fig. 3) . Each of the three transcripts showed high enrichment within the LCM-collected NMJ fractions.
We then produced affinity-purified polyclonal peptide antibodies against the three proteins. Two nonoverlapping 18-mer peptides were designed against each protein, and affinity-purified antibodies were developed. Because of the low concentration of NMJ protein in total muscle homogenates, we focused on characterization of immunoreactive protein by immunostaining of frozen sections. All three proteins showed costaining with BTX, indicating preferential expression and localization to the NMJ (Fig. 5) . In situ hybridization of DUSP6 mRNA also validated enrichment of this message to the NMJ (Fig. 4) . We note that the NMJ material contains terminal glial cells as well as the motor neuron terminal and possible contaminating connective tissue and neighboring non-NMJ myonuclei. However, we feel that these three transcripts are not expressed in glia or motor neurons, as immunoblotting of sciatic nerve tested negative in all three (data not shown). Thus we conclude that these three proteins are novel components of the NMJ.
DUSP6. Muda et al. (26) , using Northern analysis, showed that DUSP6 expression level was high in lungs; low in heart, brain, spleen, liver, and kidney; and undetectable in skeletal muscle. This is not surprising, since the small size of NMJs could contribute to the lack of protein detection. Similarly, nestin, a component of the NMJ, was originally reported as absent in adult muscle (39) .
DUSP6 is a member of a phosphatase family [dual-specificity (threonine/tyrosine) phosphatases; DSPs] known to bind and inactivate MAPKs through dephosphorylation of key sites within the MAPK proteins. MAPKs play an important role in mediating intracellular signaling events, mitogenic signal transduction, survival, stress response, and programmed cell death. In response to extracellular stimuli, MAPKs are activated by phosphorylation by threonine/tyrosine dual-specificity MAPK kinases (MAPKKs). Once activated, MAPKs activate a series of substrates that lead to changes in the transcription of specific genes. DUSP6 (also called MKP3, PYST1, rVH6) is a 42-kDa cytoplasmic protein that dephosphorylates the "classical" growth factor-activated MAPKs, ERK1 and ERK2, but not stress-activated MAPKs (17, 27) . ERK is downstream of both of the key NMJ components, agrin and neuregulin-1 (see above), and our data suggest that DUSP6 may be the relevant phosphatase that regulated the phosphorylation status of ERK1/2 at the NMJ. Interestingly, ERK2 has been shown to directly interact with the NH 2 -terminal noncatalytic domain of DUSP6 (17, 27) .
Our data set up the hypothesis that DUSP6 may negatively regulate agrin-and neuregulin-activated kinases at the NMJ. ERK1 transmits downstream signals, in part, through Src homology (SH)2/SH3 domain-containing proteins, including one known as v-Crk. Transgenic mice overexpressing v-Crk show abnormal NMJs, consistent with the importance of ERK1 signaling for appropriate NMJ structure and function (29, 41, 42, 49) . The kinases discussed here likely work at the level of signaling via protein phosphorylation, and such signaling processes are not measured by the mRNA profiling reported here. Further functional studies of these proteins are required to assess the role of DUSP6 at the NMJ, including its protein targets.
RRBP1. The primary structure of RRBP1 consists of a hydrophobic NH 2 -terminus that includes a membrane-binding domain, a highly conserved basic tandem repeat (ribosomebinding domain), and an acidic coiled-coil COOH-terminal domain with an unknown function (47) . There is recent evidence that RRBP1 may have a role in neuronal synapses, as it has been shown to bind KIF5B, and KIF5B in turn is known to bind synaptic proteins [synaptosomal-associated protein (SNAP)-24] at the NMJ (10, 46) . RRBP1 has been studied in yeast, where it is a member of the endoplasmic reticulum (ER) stress response and associated unfolded-protein response (UPR). In yeast, RRBP1 (p180) stabilizes mRNAs (5, 40, 47) . Hyde et al. (18) showed that expression of exogenous p180 in yeast stabilizes mRNAs that are targeted to the secretory pathway, and p180-mediated stabilization was shown to be UPR independent. Expression of p180 was shown to regulate RNA stability at the level of mRNA turnover by targeting it to the ER membrane, rather than at the transcription level. This is achieved possibly by localizing mRNAs to the ER membrane and saving them from cell cycle-dependent degradation. Our data suggest the model where RRBP1 may be responsible for stabilizing the highly active gene transcriptional machinery of subjunctional myonuclei.
VPS26. Organelles in eukaryotic cells are maintained by their specific organelle sorting proteins. Mannose-6-phosphate receptors (MPRs) mediate the vesicular transport to mammalian lysosomes by cycling between the trans-Golgi network (TGN) and a prelysosomal endosome (21) . Cation-independent (CI) MPRs and cation-dependent (CD) MPRs are the two distinct MPRs that play a central role in the cycling process. In yeast, a complex of five proteins (Vps35p, 29p, 26p, 17p, and 5p) named "retromer" plays a role in the retrieval of some receptors (36) (37) (38) . Vps26p, which directly binds to Vps35p, plays an important role in stabilizing this retromer complex (28) . Little is known about the molecular mechanisms regulating the retrieval of MPRs. Our observation that VPS26 is NMJ associated may suggest the role of this protein in NMJ stability by maintaining/retrieving NMJ-bound receptors. Therefore, VPS26 may play its role once the assembly of different NMJ complexes is accomplished. This may explain the relatively low expression of VPS27 in the muscle regeneration time series (Fig. 6) . , and VPS26) NMJassociated genes. Query of DUSP6 showed highest expression at 2-3 days during regeneration (5-fold increase relative to time 0 at 2 days postinjection), which preceded the upregulation of ␣-AChR (10-fold at 3 days) and nestin (4.5-fold at 3.5 days postinjection). RRBP1 showed transient induction, with a peak expression at 2 days (Ͼ2-fold), whereas VPS26 was expressed at relatively low levels.
THREE NOVEL COMPONENTS OF THE NEUROMUSCULAR JUNCTION
